Addus HomeCare Corp(ADUS)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #506 of 2,879 stocksTOP 25%
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
ADUS Stock Analysis & AI Quality Score
AI stock analysis and institutional research for Addus HomeCare Corp (ADUS), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores ADUS at 66.7/100 on a 32-signal composite quality model, placing it at rank #506 of 2,879 stocks — the top 25% of the AI-ranked universe. ADUS scores in the top quartile across institutional flow (82.4), balance sheet strength (76.2), revenue growth (75.3). Based on the latest XBRL financial filings (Q1 2026), Addus HomeCare Corp reports quarterly revenue of $363.6M, net income of $25.1M, an operating margin of 9.4%. Top institutional holders of ADUS by reported 13-F value include BlackRock,, Capital Research Global Investors, WASATCH ADVISORS, based on the most recent SEC filings. ADUS trades on the Nasdaq exchange and files with the SEC under CIK 1468328. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ADUS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Addus HomeCare Corp directly from SEC EDGAR. Addus HomeCare Corp's 13F Pro composite quality score has ranged between 8 and 73 since 2021, currently 66.7 — an improving long-term trajectory across 56 quarterly and live scoring snapshots.
What's Driving ADUS's Business? Latest 10-Q Breakdown
✓ 20/20 datapoints verifiedAI-extracted from Addus HomeCare Corp's 10-Q filed 2026-05-05 — Q1 2026 (quarter ended March 31, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.
Q1 revenue reached $363.6M (+7.7% YoY) with net income of $25.1M (+18.1% YoY); Personal Care segment drove growth with 8.8% revenue increase on 5.2% billable hour gains.
Biggest Revenue Drivers
Total revenue: $363.6M+7.7% YoY
Organic growth in billable hours combined with Gold Horses and Helping Hands acquisitions.
Organic growth in average daily census, partially offset by decrease in revenue per patient day.
Lower volumes including lower recertifications and visits; continued payor mix management efforts.
Largest Expense Items
Direct care wages, payroll taxes, benefits, workers' compensation and employee travel costs.
Increased by acquisition activity, including administrative employee wages, bonuses, taxes and benefits from Gold Horses and Helping Hands acquisitions.
Lower average outstanding borrowings and lower weighted average interest rate on credit facility.
Margins: Gross profit margin stable at 31.9% YoY; operating margin improved to 9.4% from 9.0% as operating expense ratio declined to 22.5% from 22.9% YoY despite acquisition integration costs.
Watch Items from the Filing
- Illinois Department on Aging accounted for 17.8% of total net service revenues (Q1 2026) vs. 18.5% (Q1 2025); represents 32.1% of total revenues from Illinois operations and 23.1% of net accounts receivable.
- Home Health segment revenue declined 7.0% YoY with organic revenue growth of -6.6%; segment operating margin compressed despite margin improvements, indicating volume pressure.
- Government stimulus advances (ARPA funding) of $14.6M deferred on balance sheet as of March 31, 2026; subject to recoupment if not expended on approved uses by September 30, 2026.
- Company divested New York personal care operations effective October 2024 due to CDPAP uncertainty; $2.3M deferred payment liability still outstanding related to transaction.
AI-extracted and verified against SEC EDGAR filing text. Not investment advice.
Revenue
Q1 2026
$363.6M
Net Income
Q1 2026
$25.1M
Free Cash Flow
Q1 2026
$50.7M
Operating Margin
Q1 2026
9.4%
D/E Ratio
Q1 2026
0.08
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · Pro+Revenue
+23.2% YoYNet Income
+30.3% YoYOperating Income
+35.0% YoYEPS (Diluted)
+23.4% YoYTotal Assets
+1.7% YoYTotal Debt
-44.6% YoYOp. Cash Flow
-4.2% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2020 | FY 2018 |
|---|---|---|---|---|---|---|
| Revenue | $1.42B +23.2% | $1.15B +9.1% | $1.06B +11.3% | $951.1M +24.4% | $764.8M +48.0% | $516.6M |
| Net Income | $95.9M +30.3% | $73.6M +17.7% | $62.5M +35.8% | $46.0M +38.9% | $33.1M +101.6% | $16.4M |
| Operating Income | $138.6M +35.0% | $102.7M +12.9% | $91.0M +32.3% | $68.7M +54.4% | $44.5M +95.0% | $22.8M |
| EPS (Diluted) | $5.22 +23.4% | $4.23 +10.4% | $3.83 +34.9% | $2.84 +36.5% | $2.08 +56.4% | $1.33 |
| Total Assets | $1.44B +1.7% | $1.41B +37.9% | $1.02B +9.2% | $938.0M +5.1% | $892.6M +151.2% | $355.4M |
| Total Debt | $121.0M -44.6% | $218.4M +76.0% | $124.1M -5.8% | $131.8M -32.7% | $195.8M +1029.0% | $17.3M |
| Operating Cash Flow | $111.5M -4.2% | $116.4M +3.7% | $112.2M +6.8% | $105.1M -3.9% | $109.4M +229.5% | $33.2M |
AI Insight: ADUS Financial Trends
ADUS delivers 27% revenue growth and near-complete debt paydown over eight quarters, with Q1 2026 operating cash flow hitting a multi-quarter high of $52M.
• Revenue grew 27% from $287M in Q2 2024 to $364M in Q1 2026, reflecting consistent top-line momentum.
• Operating margin expanded from ~9.1% in Q2 2024 to ~9.3% in Q1 2026, with a peak of ~11.3% in Q4 2025.
• Total debt plummeted from $218M in Q4 2024 to $91M in Q1 2026, as equity simultaneously grew to $1,116M.
• Operating cash flow was volatile — swinging between $10M (Q4 2024) and $52M (Q1 2026) — suggesting lumpy working capital cycles.
⚠ Q1 2026 revenue dipped to $364M from Q4 2025's $373M — first sequential decline in the series; worth monitoring for trend break.
⚠ Net income fell from $30M in Q4 2025 to $25M in Q1 2026 — sharpest quarter-over-quarter drop in the dataset.
⚠ Rapid debt reduction to $91M improves financial flexibility, but acquisition-driven debt spikes (as seen in Q4 2024) remain a latent risk.
AI Insight: ADUS Ratio Trends
Q4 2025 delivered a standout margin spike — operating margin hit 11.3% and ROIC reached 14.0% — while leverage has nearly vanished with D/E at 0.08.
• Operating margin surged to 11.3% in Q4 2025, the highest in the dataset, before normalizing to 9.4% in Q1 2026.
• ROIC expanded from 9.0% in Q4 2024 to 14.0% in Q4 2025, a 500bp improvement over four quarters.
• D/E ratio declined steadily from 0.23 in Q4 2024 to 0.08 in Q1 2026, signaling rapid debt paydown.
⚠ Q4 2025 margin spike looks like a one-off; Q1 2026 operating margin reverted to 9.4%, near the prior range.
⚠ ROA dropped to 5.5% in Q4 2024 — coinciding with peak D/E of 0.23 — worth monitoring if leverage rises again.
Get alerted when ADUS's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Addus HomeCare Corp including:
Top Institutional Holders of ADUS
BlackRock, Inc.
$289.4M3,090,230 shCapital Research Global Investors
$143.8M1,535,324 shWASATCH ADVISORS LP
$81.3M867,825 shVANGUARD CAPITAL MANAGEMENT LLC
$73.5M784,411 shDIMENSIONAL FUND ADVISORS LP
$69.7M744,127 shSILVERCREST ASSET MANAGEMENT GROUP LLC
$68.3M729,196 shSTATE STREET CORP
$67.5M721,247 shGEODE CAPITAL MANAGEMENT, LLC
$45.1M481,530 shMORGAN STANLEY
$42.0M448,913 shPRINCIPAL FINANCIAL GROUP INC
$40.7M434,471 sh
| Fund | Value | Shares |
|---|---|---|
| BlackRock, Inc. | $289.4M | 3,090,230 |
| Capital Research Global Investors | $143.8M | 1,535,324 |
| WASATCH ADVISORS LP | $81.3M | 867,825 |
| VANGUARD CAPITAL MANAGEMENT LLC | $73.5M | 784,411 |
| DIMENSIONAL FUND ADVISORS LP | $69.7M | 744,127 |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $68.3M | 729,196 |
| STATE STREET CORP | $67.5M | 721,247 |
| GEODE CAPITAL MANAGEMENT, LLC | $45.1M | 481,530 |
| MORGAN STANLEY | $42.0M | 448,913 |
| PRINCIPAL FINANCIAL GROUP INC | $40.7M | 434,471 |
More Healthcare Companies
View all Healthcare →Put ADUS on your watchlist
Track score changes the day Addus HomeCare Corp files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is ADUS a good stock to buy?
13F Pro's AI-powered analysis of Addus HomeCare Corp (ADUS) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for ADUS are available on the ADUS stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own ADUS?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling ADUS. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Addus HomeCare Corp's investment landscape.